Velon^®

Therapeutic Segment:
Anti-diabetic

Generic Name:
Vildagliptin

Description:
The active substance in Velon™, vildagliptin, is a dipeptidyl-peptidase-4 (DPP-4) inhibitor. It works by blocking the breakdown of ‘incretin’ hormones in the body. Vildagliptin also reduces the amount of glucose made by the liver, by increasing insulin levels and decreasing the levels of the hormone glucagon.

Indication:
Vildagliptin is indicated in the treatment of type 2 diabetes mellitus in adults: As monotherapy
– in patients inadequately controlled by diet and exercise alone and for whom metformin is inappropriate due to contraindications or intolerance. As dual oral therapy in combination with
– metformin, in patients with insufficient glycaemic control despite maximal tolerated dose of monothera-py with metformin,
– a sulphonylurea, in patients with insufficient glycaemic control despite maximal tolerated dose of a sulphonylurea and for whom metformin is inappropriate due to contraindications or intolerance,
– a thiazolidinedione, in patients with insufficient glycaemic control and for whom the use of a thiazolidinedione is appropriate.\ As triple oral therapy in combination with
– a sulphonylurea and metformin when diet and exercise plus dual therapy with these medicinal products do not provide adequate glycaemic control.
Vildagliptin is also indicated for use in combination with insulin (with or without metformin) when diet and exercise plus a stable dose of insulin do not provide adequate glycaemic control.

Formulation:

• Tablets

Strength:

• 50mg

Pack Size:

• 10’s